Publication | Closed Access

Nilotinib concentration in cell lines and primary CD34+ chronic myeloid leukemia cells is not mediated by active uptake or efflux by major drug transporters

Nilotinib ConcentrationHematological MalignancyOncologyMedicineMalignant Blood DisorderMajor Drug TransportersActive UptakeAnti-cancer AgentPharmacologyCell BiologyTumor MicroenvironmentCancer ResearchMyeloid Neoplasia